Arkolith/Insider Trading/OCUL/Form 4

Lindstrom Richard L MD

DirectorOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed May 12, 2025
Net Buying
Open-Market Buys
$70K
Open-Market Sells
$0
Net Open-Market Flow
$70K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2025Buy(P)10K$6.96$70K173K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-047435) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML